Stock Scorecard
Stock Summary for Edwards Lifesciences Corp (EW) - $88.01 as of 4/26/2024 3:12:47 PM EST
Total Score
12 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for EW
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for EW
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for EW
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for EW
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for EW
Financial Details for EW
Company Overview |
|
---|---|
Ticker | EW |
Company Name | Edwards Lifesciences Corp |
Country | USA |
Description | Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. |
Sector Name | LIFE SCIENCES |
Industry Name | ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES |
Most Recent Quarter | 3/31/2024 |
Next Earnings Date | 5/7/2024 |
Stock Price History |
|
Last Day Price | 88.01 |
Last Day Price Updated | 4/26/2024 3:12:47 PM EST |
Last Day Volume | 0 |
Average Daily Volume | 3,240,674 |
52-Week High | 96.12 |
52-Week Low | 60.57 |
Last Price to 52 Week Low | 45.30% |
Valuation Measures |
|
Trailing PE | 37.58 |
Industry PE | 60.69 |
Sector PE | 56.64 |
5-Year Average PE | 62.53 |
Free Cash Flow Ratio | 32.24 |
Industry Free Cash Flow Ratio | 37.87 |
Sector Free Cash Flow Ratio | 30.65 |
Current Ratio Most Recent Quarter | 3.38 |
Total Cash Per Share | 2.73 |
Book Value Per Share Most Recent Quarter | 11.83 |
Price to Book Ratio | 8.17 |
Industry Price to Book Ratio | 6.35 |
Sector Price to Book Ratio | 22.15 |
Price to Sales Ratio Twelve Trailing Months | 9.05 |
Industry Price to Sales Ratio Twelve Trailing Months | 7.00 |
Sector Price to Sales Ratio Twelve Trailing Months | 5.17 |
Share Statistics |
|
Total Shares Outstanding | 601,927,000 |
Market Capitalization | 52,975,595,270 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 2.23% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 3.60% |
Annual Earnings Growth | -7.85% |
Reported EPS 12 Trailing Months | 2.30 |
Reported EPS Past Year | 0.66 |
Reported EPS Prior Year | 2.51 |
Net Income Twelve Trailing Months | 1,402,400,000 |
Net Income Past Year | 1,402,400,000 |
Net Income Prior Year | 1,521,900,000 |
Quarterly Revenue Growth YOY | 9.50% |
5-Year Revenue Growth | 10.15% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 1,644,500,000 |
Total Cash Past Year | 1,644,500,000 |
Total Cash Prior Year | 1,215,300,000 |
Net Cash Position Most Recent Quarter | 1,047,500,000 |
Net Cash Position Past Year | 1,047,500,000 |
Long Term Debt Past Year | 597,000,000 |
Long Term Debt Prior Year | 596,300,000 |
Total Debt Most Recent Quarter | 597,000,000 |
Equity to Debt Ratio Past Year | 0.92 |
Equity to Debt Ratio Most Recent Quarter | 0.92 |
Total Stockholder Equity Past Year | 6,650,000,000 |
Total Stockholder Equity Prior Year | 5,806,700,000 |
Total Stockholder Equity Most Recent Quarter | 6,650,000,000 |
Options |
|
Put/Call Ratio | 2.45 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.95 |
MACD Signal | -0.33 |
20-Day Bollinger Lower Band | 69.15 |
20-Day Bollinger Middle Band | 84.22 |
20-Day Bollinger Upper Band | 99.28 |
Beta | 1.07 |
RSI | 42.34 |
50-Day SMA | 80.29 |
200-Day SMA | 90.51 |
System |
|
Modified | 4/27/2024 12:10:39 AM EST |